Thank you very much;
you're only a step away from
downloading your reports.
Stock Upgrades: Eli Lilly Boosted by Love and Other Drugs
Wall Street ratings agencies set the tone for today's stock market.
Justin Sharon    

Is the pharmaceutical industry about to revisit its Love and Other Drugs heyday of the 1990s? Overseas, one industry giant appears to be taking the ethos of that go-go era a little too literally even as Eli Lilly (NYSE:LLY), which owns the ED blockbuster Cialis, is once again feeling investors' infatuation. Shares hit a fresh 52-week peak on Monday, and the company offers a relatively plump dividend yield in excess of 3%.
 
Talk about Christmas in July. Sport Chalet (NASDAQ:SPCHA), famous for its Scuba Santas, surged 36.89% to easily best all Nasdaq (INDEXNASDAQ:.IXIC) issues, as stocks started the year's seventh month with Kris Kringle almost entirely alone in being underwater. The Dow (INDEXDJX:.DJI) and S&P 500 (INDEXSP:.INX) each reached fresh peaks, with a broker boost sending Netflix (NASDAQ:NFLX) surging 7.38% on the day it debuted Bad Santa. Even as Team USA lost a heartbreaker to our Flemish friends on the fútbol field, goaltender Tim Howard -- our American World Cup player to watch -- single-handedly, as one wag put it, improved the nation's savings rate. On the first day of the second quarter, Michael Lewis made an April Fool's appearance on a comedy show to talk about the rise of computers, but that was then, this is now. On the first day of the third quarter the robots of Intuitive Surgical (NASDAQ:ISRG) slipped for a second straight session, ending off 1.29%. This, as fist fights in the trading pits of New York and a stay of execution for England's open outcry system indicates that we humans happily haven't entirely been superseded by machines. Elsewhere, residents of Queens disgraced themselves by heckling a homeless shelter even as Jamie Dimon, proud product of the borough, demonstrated commendable courage and dignity.
 
Today in economics, factory orders for May are expected to contract from April's pace at 10:00 a.m. EDT. On the corporate front, Constellation Brands (NYSE:STZ) and Greenbrier Companies (NYSE:GBX) each released strong quarterly earnings earlier this morning.
 
Now let's analyze this morning's research recommendations, a group encompassing clothing companies and financial firms as well as our aforementioned Eli Lilly.

AbbVie (NYSE:ABBV): Barclays boosts the equity to Overweight from Equal Weight.
 
Alcatel-Lucent (NYSE:ALU): The French telecom firm gets moved to Overweight from Neutral at JPMorgan.
 
Baker Hughes (NYSE:BHI): Susquehanna increases the oil services outfit to Positive from Neutral with a $90 price target.
 
Bank of America (NYSE:BAC): Shares are up ahead of the open on a Buy-from-Hold hoist by Deutsche Bank. The price objective also increases, to $18 from $16.50.
 
Canadian Pacific (NYSE:CP): CIBC World Markets moves the company to Outperform from Perform.
 
Eli Lilly: Today's headline upgraded gets increased to Equal Weight from Underweight by Barclays, whose price objective is $63.
 
Liberty Media (NASDAQ:LMCA): Morgan Stanley lifts LMCA to Overweight from Equal Weight.
 
Men's Wearhouse (NYSE:MW): Shares are taken to Buy from Hold with a $67 target price at Stifel, which cites merger synergies from a recent acquisition.
 
Oracle (NASDAQ:ORCL): Atlantic Equities increases its investment assessment to Overweight from Neutral.
 
Urban Outfitters (NASDAQ:URBN): The stock is now Outperform from Neutral at Macquarie.

WebMD Health (NASDAQ:WBMD): The stock gets boosted to Buy from Hold with a $60 objective at Stifel. Catalysts include good advertising revenue growth.

Also see:

New Stock Coverage: SolarCity Doesn't Need Fireworks to Light It Up

Stock Downgrades: Monty Python Is Back, but Hormel Foods Finds We Still Don't Like Spam a Lot
< Previous
  • 1
Next >
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Stock Upgrades: Eli Lilly Boosted by Love and Other Drugs
Wall Street ratings agencies set the tone for today's stock market.
Justin Sharon    

Is the pharmaceutical industry about to revisit its Love and Other Drugs heyday of the 1990s? Overseas, one industry giant appears to be taking the ethos of that go-go era a little too literally even as Eli Lilly (NYSE:LLY), which owns the ED blockbuster Cialis, is once again feeling investors' infatuation. Shares hit a fresh 52-week peak on Monday, and the company offers a relatively plump dividend yield in excess of 3%.
 
Talk about Christmas in July. Sport Chalet (NASDAQ:SPCHA), famous for its Scuba Santas, surged 36.89% to easily best all Nasdaq (INDEXNASDAQ:.IXIC) issues, as stocks started the year's seventh month with Kris Kringle almost entirely alone in being underwater. The Dow (INDEXDJX:.DJI) and S&P 500 (INDEXSP:.INX) each reached fresh peaks, with a broker boost sending Netflix (NASDAQ:NFLX) surging 7.38% on the day it debuted Bad Santa. Even as Team USA lost a heartbreaker to our Flemish friends on the fútbol field, goaltender Tim Howard -- our American World Cup player to watch -- single-handedly, as one wag put it, improved the nation's savings rate. On the first day of the second quarter, Michael Lewis made an April Fool's appearance on a comedy show to talk about the rise of computers, but that was then, this is now. On the first day of the third quarter the robots of Intuitive Surgical (NASDAQ:ISRG) slipped for a second straight session, ending off 1.29%. This, as fist fights in the trading pits of New York and a stay of execution for England's open outcry system indicates that we humans happily haven't entirely been superseded by machines. Elsewhere, residents of Queens disgraced themselves by heckling a homeless shelter even as Jamie Dimon, proud product of the borough, demonstrated commendable courage and dignity.
 
Today in economics, factory orders for May are expected to contract from April's pace at 10:00 a.m. EDT. On the corporate front, Constellation Brands (NYSE:STZ) and Greenbrier Companies (NYSE:GBX) each released strong quarterly earnings earlier this morning.
 
Now let's analyze this morning's research recommendations, a group encompassing clothing companies and financial firms as well as our aforementioned Eli Lilly.

AbbVie (NYSE:ABBV): Barclays boosts the equity to Overweight from Equal Weight.
 
Alcatel-Lucent (NYSE:ALU): The French telecom firm gets moved to Overweight from Neutral at JPMorgan.
 
Baker Hughes (NYSE:BHI): Susquehanna increases the oil services outfit to Positive from Neutral with a $90 price target.
 
Bank of America (NYSE:BAC): Shares are up ahead of the open on a Buy-from-Hold hoist by Deutsche Bank. The price objective also increases, to $18 from $16.50.
 
Canadian Pacific (NYSE:CP): CIBC World Markets moves the company to Outperform from Perform.
 
Eli Lilly: Today's headline upgraded gets increased to Equal Weight from Underweight by Barclays, whose price objective is $63.
 
Liberty Media (NASDAQ:LMCA): Morgan Stanley lifts LMCA to Overweight from Equal Weight.
 
Men's Wearhouse (NYSE:MW): Shares are taken to Buy from Hold with a $67 target price at Stifel, which cites merger synergies from a recent acquisition.
 
Oracle (NASDAQ:ORCL): Atlantic Equities increases its investment assessment to Overweight from Neutral.
 
Urban Outfitters (NASDAQ:URBN): The stock is now Outperform from Neutral at Macquarie.

WebMD Health (NASDAQ:WBMD): The stock gets boosted to Buy from Hold with a $60 objective at Stifel. Catalysts include good advertising revenue growth.

Also see:

New Stock Coverage: SolarCity Doesn't Need Fireworks to Light It Up

Stock Downgrades: Monty Python Is Back, but Hormel Foods Finds We Still Don't Like Spam a Lot
< Previous
  • 1
Next >
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Stock Upgrades: Eli Lilly Boosted by Love and Other Drugs
Wall Street ratings agencies set the tone for today's stock market.
Justin Sharon    

Is the pharmaceutical industry about to revisit its Love and Other Drugs heyday of the 1990s? Overseas, one industry giant appears to be taking the ethos of that go-go era a little too literally even as Eli Lilly (NYSE:LLY), which owns the ED blockbuster Cialis, is once again feeling investors' infatuation. Shares hit a fresh 52-week peak on Monday, and the company offers a relatively plump dividend yield in excess of 3%.
 
Talk about Christmas in July. Sport Chalet (NASDAQ:SPCHA), famous for its Scuba Santas, surged 36.89% to easily best all Nasdaq (INDEXNASDAQ:.IXIC) issues, as stocks started the year's seventh month with Kris Kringle almost entirely alone in being underwater. The Dow (INDEXDJX:.DJI) and S&P 500 (INDEXSP:.INX) each reached fresh peaks, with a broker boost sending Netflix (NASDAQ:NFLX) surging 7.38% on the day it debuted Bad Santa. Even as Team USA lost a heartbreaker to our Flemish friends on the fútbol field, goaltender Tim Howard -- our American World Cup player to watch -- single-handedly, as one wag put it, improved the nation's savings rate. On the first day of the second quarter, Michael Lewis made an April Fool's appearance on a comedy show to talk about the rise of computers, but that was then, this is now. On the first day of the third quarter the robots of Intuitive Surgical (NASDAQ:ISRG) slipped for a second straight session, ending off 1.29%. This, as fist fights in the trading pits of New York and a stay of execution for England's open outcry system indicates that we humans happily haven't entirely been superseded by machines. Elsewhere, residents of Queens disgraced themselves by heckling a homeless shelter even as Jamie Dimon, proud product of the borough, demonstrated commendable courage and dignity.
 
Today in economics, factory orders for May are expected to contract from April's pace at 10:00 a.m. EDT. On the corporate front, Constellation Brands (NYSE:STZ) and Greenbrier Companies (NYSE:GBX) each released strong quarterly earnings earlier this morning.
 
Now let's analyze this morning's research recommendations, a group encompassing clothing companies and financial firms as well as our aforementioned Eli Lilly.

AbbVie (NYSE:ABBV): Barclays boosts the equity to Overweight from Equal Weight.
 
Alcatel-Lucent (NYSE:ALU): The French telecom firm gets moved to Overweight from Neutral at JPMorgan.
 
Baker Hughes (NYSE:BHI): Susquehanna increases the oil services outfit to Positive from Neutral with a $90 price target.
 
Bank of America (NYSE:BAC): Shares are up ahead of the open on a Buy-from-Hold hoist by Deutsche Bank. The price objective also increases, to $18 from $16.50.
 
Canadian Pacific (NYSE:CP): CIBC World Markets moves the company to Outperform from Perform.
 
Eli Lilly: Today's headline upgraded gets increased to Equal Weight from Underweight by Barclays, whose price objective is $63.
 
Liberty Media (NASDAQ:LMCA): Morgan Stanley lifts LMCA to Overweight from Equal Weight.
 
Men's Wearhouse (NYSE:MW): Shares are taken to Buy from Hold with a $67 target price at Stifel, which cites merger synergies from a recent acquisition.
 
Oracle (NASDAQ:ORCL): Atlantic Equities increases its investment assessment to Overweight from Neutral.
 
Urban Outfitters (NASDAQ:URBN): The stock is now Outperform from Neutral at Macquarie.

WebMD Health (NASDAQ:WBMD): The stock gets boosted to Buy from Hold with a $60 objective at Stifel. Catalysts include good advertising revenue growth.

Also see:

New Stock Coverage: SolarCity Doesn't Need Fireworks to Light It Up

Stock Downgrades: Monty Python Is Back, but Hormel Foods Finds We Still Don't Like Spam a Lot
< Previous
  • 1
Next >
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
EDITOR'S PICKS
 
WHAT'S POPULAR